2023 annual financial data
Apogee Therapeutics 2023 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -93,003,000 USD and net income was -83,985,000 USD.
Operating cash flow was -74,761,000 USD.
Get free Apogee Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -93,003,000 USD
- Net income
- -83,985,000 USD
- Operating cash flow
- -74,761,000 USD